Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • My alerts

Search

  • Advanced search
eNeuro
  • My alerts

eNeuro

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
PreviousNext
Research ArticleNegative Results, Disorders of the Nervous System

Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo

Georgia Dermentzaki, Kristin A. Politi, Lei Lu, Vartika Mishra, Eduardo J. Pérez-Torres, Alexander A. Sosunov, Guy M. McKhann II, Francesco Lotti, Neil A. Shneider and Serge Przedborski
eNeuro 28 January 2019, 6 (1) ENEURO.0308-18.2018; DOI: https://doi.org/10.1523/ENEURO.0308-18.2018
Georgia Dermentzaki
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin A. Politi
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Lu
2Department of Neurology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vartika Mishra
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eduardo J. Pérez-Torres
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander A. Sosunov
3Department of Neurological Surgery, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy M. McKhann II
3Department of Neurological Surgery, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Lotti
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil A. Shneider
2Department of Neurology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Serge Przedborski
1Department of Pathology and Cell Biology, Columbia University, New York, NY 10032
2Department of Neurology, Columbia University, New York, NY 10032
4Center for Motor Neuron Biology and Disease, Columbia University, New York, NY 10032
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Upregulation of core necroptosis components in the spinal cord of symptomatic Tg SOD1G93A mice. Lumbar spinal cords, from 12- and 15-week-old Tg SOD1G93A, WT SOD1, and NTg mice, were isolated and processed for mRNA and protein (RIPA or urea extraction) expression of RIPK1, RIPK3, MLKL, and p-MLKL. A, Quantification of Ripk1, Ripk3, and Mlkl mRNA from 12-week-old mice. Gapdh: housekeeping gene. A significant increase was detected for Ripk3 in Tg SOD1G93A compared to Tg SOD1WT (p = 0.0021) and NTg (p = 0.0076) at 12 weeks. B, Quantification of Ripk1, Ripk3, and Mlkl mRNA in spinal cords of 15-week-old mice. Gapdh: housekeeping gene. A significant increase was detected for Ripk1 (p = 0.0009, vs Tg SOD1WT; p = 0.0020, vs NTg) and Ripk3 (p = 0.0115; vs Tg SOD1WT, p = 0.0067; vs NTg) but not for Mlkl in Tg SOD1G93A compared to Tg SOD1WT and NTg mice at 15 weeks. C, Western blotting (RIPA) for RIPK1 in spinal cord of NTg, Tg SOD1WT, and Tg SOD1G93A 15-week-old mice. β-ACTIN, GAPDH: loading control. Specificity of the RIPK1 band was confirmed following downregulation of RIPK1 with specific lentiviral shRNA in mouse PMN cultures (mPMNs). D, Quantification of RIPK1 protein levels. RIPK1 protein is significantly increased in Tg SOD1G93A samples compared to Tg SOD1WT (p = 0.0279) and NTg (p = 0.0033) mice. Results are presented as mean ± SEM. Statistical analysis was performed via one-way ANOVA followed by Tukey’s post hoc analysis; n = 3 biological replicates per genotype. E, Western blotting (RIPA) for RIPK3 showed no specific signal at the expected 55 kDa in spinal cord (NTg and Tg SOD1G93A). Non-specific band at 47 kDa is designated as an asterisk (*). NTg spleen: positive control tissue, Ripk3−/− spleen and Tg SOD1G93A;Ripk3−/− spinal cord: negative control tissue. F, Western blotting (urea) for RIPK3 antibody showed no specific signal at the expected 55 kDa in spinal cord (NTg and Tg SOD1G93A). Ripk3−/− spinal cord: negative control tissue. G, Western blotting (RIPA) for MLKL showed no specific signal at the expected 55 kDa in spinal cord. NIH 3T3: positive control cell lysate. H, Western blotting (urea) for MLKL showed no specific signal at the expected 55 kDa in spinal cord (NTg and Tg SOD1G93A). NIH 3T3: positive control cell lysate. I, Western blotting for p-MLKL (RIPA) showed no signal at the expected 55 kDa. TSZ-treated L929 cells: control cell lysate.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    RIPK1 expression in brain cortex from ALS patients. Postmortem motor cortex (Brodmann’s area 4) from sporadic ALS, SOD1 ALS, and non-ALS human brains was homogenized and processed for RIPK1 protein expression. Western blotting for RIPK1 protein. Two different antibodies against RIPK1 were used (A, AB_397831; B, AB_394014). C, Quantification of RIPK1 protein levels. β-ACTIN, loading control. No significant differences were detected for RIPK1 between sporadic ALS, SOD1 ALS, and non-ALS human brain samples. Results are presented in a scatter dot plot. Line = mean. Statistical analysis was performed via Student’s t test: t(10) = 0.579, p = 0.575; n = 4; non-ALS, n = 6; sporadic ALS, and n = 2; SOD1 ALS.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Ripk3−/− MNs are resistant to Tg SOD1G93A astrocyte-mediated toxicity. MNs, isolated from E12.5 Ripk3+/+ or Ripk3−/− mice, were co-cultured on primary astrocyte monolayers from Tg SOD1G93A or NTg mice for 7 d. A, Representative images of MNs assessed using SMI32 immunolabeling. Scale bar: 50 μm. B, Quantification of MN number. Ripk3+/+ MN number was significantly reduced on SOD1G93A astrocytes (p = 0.0013) compared to NTg. Ripk3−/− MN number did not differ between NTg or SOD1G93A astrocytes and was significantly increased (p = 0.0370) compared to Ripk3+/+ MN number on SOD1G93A astrocytes. Results are presented as a mean ± SEM. Statistical analysis was performed via two-way ANOVA; n = 3 biological replicates per genotype. *p ≤ 0.05; **p ≤ 0.01.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Onset and survival in Tg SOD1G93A;Ripk3−/− mice. Mice were separated by genotype and sex for onset (%) and survival (%), and data were plotted as Kaplan–Meier curves. A, Onset in Tg SOD1G93A;Ripk3−/− (median = 155) and Tg SOD1G93A;Ripk3+/+ (median = 151), p = 0.06; male and female mice. B, Onset in Tg SOD1G93A;Ripk3−/− (median = 155) and Tg SOD1G93A;Ripk3+/+ (median = 152), p = 0.005; male mice. C, Onset in Tg SOD1G93A;Ripk3−/− (median = 148) and Tg SOD1G93A;Ripk3+/+ (median = 155), p = 0.836; female mice. D, Survival in Tg SOD1G93A;Ripk3−/− (median = 169) and Tg SOD1G93A;Ripk3+/+ (median = 163), p = 0.145; male and female mice. E, Survival in Tg SOD1G93A;Ripk3−/− (median = 178) and Tg SOD1G93A;Ripk3+/+ (median = 157), p = 0.017; male mice. F, Survival in Tg SOD1G93A;Ripk3−/− (median = 163) and Tg SOD1G93A;Ripk3+/+ (median = 170), p = 0.340; female mice. For A, D, 10 Tg SOD1G93A;Ripk3+/+ mice and 12 Tg SOD1G93A;Ripk3−/− mice. For B, E, 5 Tg SOD1G93A;Ripk3+/+ mice and 7 Tg SOD1G93A;Ripk3−/− mice. For C, F, 5 Tg SOD1G93A;Ripk3+/+ mice and 5 Tg SOD1G93A;Ripk3−/− mice. Statistical analysis was performed via log-rank Mantel–Cox test.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Functional motor tests on Tg SOD1G93A;Ripk3−/− mice. Mice were separated by genotype and sex for grip strength analysis. A, Inverted grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ male and female mice. B, Inverted grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ male mice. C, Inverted grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ female mice. D, Loaded grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ male and female. E, Loaded grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ male mice. F, Loaded grid score in Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ female mice. For A, D, 14 Tg SOD1G93A;Ripk3+/+ mice and 17 Tg SOD1G93A;Ripk3−/− mice. For B, E, 8 Tg SOD1G93A;Ripk3+/+ mice and 10 Tg SOD1G93A;Ripk3−/− mice. For C, F, 6 Tg SOD1G93A;Ripk3+/+ mice and 7 Tg SOD1G93A;Ripk3−/− mice. Statistical analysis was performed by unpaired t test, two-tailed in selected time points using post hoc Bonferroni correction.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    MN number and NMJ innervation is not improved in Tg SOD1G93A;Ripk3−/− mice. A, Representative images of ChAT+ cells in lumbar (L4-L5) ventral horns from P140 (close to end-stage) mice (fluorescent microscope; 10× magnification). Scale bar: 50 μm. B, Quantification of MN number, expressed as average number of neurons per hemisection (20 μm). Statistical significant difference was detected between NTg (Ripk3+/+ and Ripk3 −/−) and Tg (SOD1G93A;Ripk3+/+ and SOD1G93A;Ripk3−/−), p < 0.0001. No difference was detected between Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ mice. Results are presented as a mean ± SEM. Statistical analysis was performed via two-way ANOVA followed by Newman–Keuls post hoc test; n = 3 biological replicates per genotype. C, Representative images of NMJ assessed by the expression of BTX (red, postsynaptic) and VAChT (green, presynaptic) in the TA muscle of P120 mice. Left column, Tg SOD1G93A;Ripk3+/+. Right column, Tg SOD1G93A;Ripk3−/− mice. Scale bar: 100 μm. D, Quantification of NMJs from 20-μm sections (n = ∼100 NMJs). NMJs were categorized as innervated (complete colocalization of BTX and VAChT), partial (partial colocalization of BTX and VAChT), or denervated (no colocalization between BTX and VAChT) and are presented as a percentage of the total NMJ number counted. No difference was observed in the number of innervated, partially innervated, and denervated NMJs between Tg SOD1G93A;Ripk3−/− and Tg SOD1G93A;Ripk3+/+ mice. Results are presented as a mean ± SEM. Statistical analysis was performed via unpaired Student’s t test, two-tailed; n = 3 biological replicates per genotype. ***p ≤ 0.001.

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    MN myelination morphology is not impaired in Tg SOD1G93A P90 mice. A, Gross morphology of the spinal cords (L1-L5) in transverse sections. B, Enlarged boxed areas in A indicate areas of white matter of ventral horn with adjacent ventral root. Note myelin degeneration only in Tg SOD1G93A (arrows in B, marked only few). A, B, Semithin sections, stained with toluidine blue. C, Ultrastructure of myelinated fibers in white matter of ventral horn. D, Ultrastructure of ventral roots. Note that myelin morphology is not impaired in both genotypes in C, D. All images in the horizontal panels were obtained at the same magnification. E, Ultrastructure of white matter ventral horn. F, Enlarged boxed areas in E. Note the decompacted morphology of myelin in both genotypes. Vertical columns correspond to the mice genotype indicated at the top. Scale bars: 0.5 cm (A), 25 μm (B), 10 μm (C–E), 5 μm (F).

  • Figure 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 8.

    Characterization of the Optn−/− mouse. A, Schematic of the Optn−/− mice. Optn knock-out allele was generated by two steps crossing of FLPase and CRE mice separately with Optn tm1a(EUCOMM)Wtsi mice to trim out the critical exon. B, Western blotting for OPTN expression in Optn+/− (+/−), Optn−/− (−/−), and control (+/+) spinal cord tissue. GAPDH, loading control. C, Representative images of ChAT+ cells in lumbar ventral spinal cord (L4-L5) from one-year-old Optn+/+ and Optn−/− mice. Scale bar: 50 μm. D, Quantification of medial motor column (MMC) MN number, expressed in average number of neurons per hemisection. Results are presented as a mean ± SEM. Statistical analysis was performed via unpaired Student’s t test; n = 3 biological replicates per genotype. E, Representative images of NMJ, of the TA muscle, assessed by the expression of BTX (red, postsynaptic) and Syn (green, presynaptic) from one-year-old Optn−/− mice. Colocalization of BTX and Syn represents an innervated NMJ. Scale bar: 50 μm. F, Quantification of innervated NMJs (%) in the Optn+/+, Optn+/−, and Optn−/− mice. Results are presented as mean ± SEM. Statistical analysis was performed via unpaired Student’s t test, two-tailed; n = 3 biological replicates per genotype. G, Ultrastructure of white matter ventral horn in the Optn+/+ and Optn−/− mice. H, Ultrastructure of ventral roots in the Optn+/+ and Optn−/− mice. Note that myelin does not differ in both genotypes of mice in G, H. Scale bar: 10 μm (G, H).

Tables

  • Figures
    • View popup
    Table 1.

    ALS patient samples history

    DiseaseSexAge at deathPMI cold (HH:MM)PMI frozen (HH:MM)Age at onsetDisease duration (months)Notes
    NON-ALS #1M824:5511:20..Neuro normal
    NON-ALS #2F546:4116:36..Neuro normal
    NON-ALS #3F624:334:12..Hypoxic ischemic encephalopathy
    NON-ALS #4M60N/A10:08..Neuro normal
    SALS #5M674:4019:206519Right lower extremity onset
    SALS #6M564:5310:575418Lower extremity onset
    SALS #7F723:0119:577029Diffuse weakness, proximal involvement
    SALS #8M56N/A13:175433Lower extremity onset, used high dose steroids (prednisone, decadron, testosterone), angiogenin mutation (I70V)
    SALS #9F71N/A5:117030Bulbar onset
    SALS #10F695:305:006718Bulbar onset
    FALS #11F5212:454:005024SOD1 mutation (L144F)
    FALS #12F32N/A5:102930SOD1 mutation (A5V)
    • SALS, sporadic ALS; FALS; familial ALS; M, male; F, female, N/A, not available; PMI, postmortem interval.

Back to top

In this issue

eneuro: 6 (1)
eNeuro
Vol. 6, Issue 1
January/February 2019
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
Georgia Dermentzaki, Kristin A. Politi, Lei Lu, Vartika Mishra, Eduardo J. Pérez-Torres, Alexander A. Sosunov, Guy M. McKhann, Francesco Lotti, Neil A. Shneider, Serge Przedborski
eNeuro 28 January 2019, 6 (1) ENEURO.0308-18.2018; DOI: 10.1523/ENEURO.0308-18.2018

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Deletion of Ripk3 Prevents Motor Neuron Death In Vitro but not In Vivo
Georgia Dermentzaki, Kristin A. Politi, Lei Lu, Vartika Mishra, Eduardo J. Pérez-Torres, Alexander A. Sosunov, Guy M. McKhann, Francesco Lotti, Neil A. Shneider, Serge Przedborski
eNeuro 28 January 2019, 6 (1) ENEURO.0308-18.2018; DOI: 10.1523/ENEURO.0308-18.2018
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • ALS
  • mice
  • motor neuron
  • necroptosis
  • neurodegeneration
  • Ripk3

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

Negative Results

  • Closed-Loop Acoustic Stimulation Enhances Sleep Oscillations But Not Memory Performance
  • Cyfip1 Haploinsufficiency Does Not Alter GABAA Receptor δ-Subunit Expression and Tonic Inhibition in Dentate Gyrus PV+ Interneurons and Granule Cells
  • Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Show more Negative Results

Disorders of the Nervous System

  • Closed-Loop Acoustic Stimulation Enhances Sleep Oscillations But Not Memory Performance
  • Cyfip1 Haploinsufficiency Does Not Alter GABAA Receptor δ-Subunit Expression and Tonic Inhibition in Dentate Gyrus PV+ Interneurons and Granule Cells
  • Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.